JPRN-jRCT2072230089尚未招募3 期
Confirmatory trial with dMD-003- Non-inferiority confirmatory study of dMD-003 to Seprafilm in patients with primary rectal cancer scheduled to undergo temporary loop ileostomy
Aihara Fumiaki0 个研究点目标入组 150 人开始时间: 2023年11月11日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •(1) Patients with initial and primary rectal cancer.
- •(2) Patients with cStage 0 to cStage III cancer.
- •(3) Patients who are scheduled to undergo laparoscopic or robot-assisted rectal resection in which a temporary ileostomy is scheduled to be performed.
- •Other criteria.
排除标准
- •(1) Patients who have previously undergone surgery in the abdominal cavity (excluding appendicitis surgery).
- •(2) Patients with cStage IV cancer.
- •(3) Patients who are scheduled to have samples removed from a site other than the midline incision.
- •Other criteria.
研究者
相似试验
尚未招募
3 期
D3-Penta 21- A randomised non-inferiority trial with nested PK to assess DTG/3TC fixed dose formulations for the maintenance of virological suppression in children with HIV infection aged 2 to <15 years oldHIV/AIDSPACTR202112758618724Fondazione Penta Onlus Penta370
招募中
1 期
Trial in patients with newly diagnosed myeloma to assess non-inferiority of induction therapy with isatuximab/lenalidomide/ bortezomib/ dexamethasone when isatuximab is administered subcutaneously versus intravenouslyewly diagnosed symptomatic multiple myelomaMedDRA version: 21.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2022-000996-38-ATRuprecht-Karls-Universität Heidelberg, Medical Faculty represented by Universitätsklinikum Heidelberg514
招募中
1 期
Trial in patients with newly diagnosed myeloma to assess non-inferiority of induction therapy with isatuximab/lenalidomide/ bortezomib/ dexamethasone when isatuximab is administered subcutaneously versus intravenouslyewly diagnosed symptomatic multiple myelomaMedDRA version: 21.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2022-000996-38-DERuprecht-Karls-Universität Heidelberg, Medical Faculty represented by Universitätsklinikum Heidelberg514
招募中
不适用
Effectiveness of albumin (biological) in Liver Disease.CTRI/2020/03/023993Institute of Liver and Biliary Sciences
已完成
2 期
Telescopic coated dental needles vs. conventional syringe system: comparing pain and anxiety in patientsIRCT2015113025300N1Vice chancellor for research, Kerman University of Medical Sciences100